Strategic collaborations Sanofi US actively partners with national health organizations and community health workers to advance sustainable healthcare delivery, presenting potential co-marketing, field-services, or educational program opportunities for expanded reach and value-based care initiatives.

Sustainability grants Recent funding for energy efficiency and emissions reductions at vaccine manufacturing facilities signals openness to grants, compliance tech, and energy management solutions that could be bundled with manufacturing process optimization and reporting tools.

Intellectual property focus Sanofi’s patent litigation activity around mRNA technology indicates a strategic emphasis on protecting IP assets; opportunities exist for advanced IP management, compliance, and secure collaboration platforms to support R&D and partnerships.

Leadership and strategy Change in executive leadership with a focus on preserving Dupixent revenue beyond 2031 suggests openness to strategic planning services, portfolio optimization, and data-driven market access or lifecycle management analytics.

Regulatory and risk Ongoing legal actions related to program integrity and provider kickbacks highlight a potential need for governance, risk compliance, and anti-fraud digital solutions that can help ensure regulatory adherence across US operations.